SCHEMBL6858213

SCHEMBL6858213

COc1ncc(-c2ccc(/C=C3/NC(=N)NC3=O)o2)c(OC)n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 11/20 0.39
▸ GSK3A P49840 10/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PIK3CG P48736 2/20 0.36
▸ FAAH O00519 1/20 0.36
▸ CES1 P23141 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ RECQL P46063 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ QPCT Q16769 1/20 0.34
▸ QPCTL Q9NXS2 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALPL P05186 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PRF1 P14222 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860968 0.81 GSK3A (0.44) GSK3BGSK3ADUSP3PIK3CGMAPT
SCHEMBL1116221 0.78 HTR2A (0.41) GSK3BGSK3ADUSP3PIK3CGFAAH
SCHEMBL1116224 0.78 HTR2A (0.41) GSK3BGSK3ADUSP3PIK3CGFAAH
SCHEMBL1116268 0.77 ALDH1A1 (0.43) PIK3CGFAAHCES1MAPTLMNA
SCHEMBL6859360 0.71 GSK3A (0.43) GSK3BGSK3ADUSP3PIK3CGMAPT
SCHEMBL6858664 0.63 GSK3A (0.74) GSK3BGSK3ADUSP3MAPTRECQL
SCHEMBL30961329 0.62 FAAH (0.46) PIK3CGFAAHCES1QPCTQPCTL
SCHEMBL6858605 0.62 PLAU (0.36) FAAHCES1QPCTQPCTL
SCHEMBL16734472 0.60 PIM1 (0.44) GSK3BPIK3CGMAPTLMNAMEN1
SCHEMBL29225233 0.60 FAAH (0.45) FAAHCES1MAPTLMNAQPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback